Jonathan Anderman Compass Therapeutics, Inc. (CMPX) insider trading activity

CMPX Quotes by TradingView

Jonathan Anderman is General Counsel of Compass Therapeutics, Inc.. Currently has a direct ownership of 171,000 shares of CMPX, which is worth approximately $834,480. The most recent transaction as insider was on Jan 02, 2026, when has been sold 150,000 shares (Common Stock) at a price of $5.17 per share, resulting in proceeds of $775,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 171K
714.29% 3M change
n/a 12M change
Total Value Held $834,480

Jonathan Anderman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
BUY
Grant, award, or other acquisition
$775,500 $5.17 p/Share
150,000 Added 46.73%
171,000 Common Stock
Apr 07 2025
BUY
Open market or private purchase
$30,800 $1.54 p/Share
20,000 Added 48.78%
21,000 Common Stock
JA

Jonathan Anderman

General Counsel
Boston, MA

Track Institutional and Insider Activities on CMPX

Follow Compass Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CMPX shares.

Notify only if

Insider Trading

Get notified when an Compass Therapeutics, Inc. insider buys or sells CMPX shares.

Notify only if

News

Receive news related to Compass Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CMPX